These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7082777)

  • 1. The pharmacokinetics and metabolism of 14C-carprofen in man.
    Ray JE; Wade DN
    Biopharm Drug Dispos; 1982; 3(1):29-38. PubMed ID: 7082777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of carprofen, a nonsteroid anti-inflammatory agent, in rats, dogs, and humans.
    Rubio F; Seawall S; Pocelinko R; DeBarbieri B; Benz W; Berger L; Morgan L; Pao J; Williams TH; Koechlin B
    J Pharm Sci; 1980 Nov; 69(11):1245-53. PubMed ID: 7452450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of labetalol by animals and man.
    Martin LE; Hopkins R; Bland R
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and pharmacokinetics of 14C-pentoxifylline in healthy volunteers.
    Bryce TA; Chamberlain J; Hillbeck D; Macdonald CM
    Arzneimittelforschung; 1989 Apr; 39(4):512-7. PubMed ID: 2751739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of lorazepam. I. Absorption and disposition of oral 14C-lorazepam.
    Greenblatt DJ; Schillings RT; Kyriakopoulos AA; Shader RI; Sisenwine SF; Knowles JA; Ruelius HW
    Clin Pharmacol Ther; 1976 Sep; 20(3):329-41. PubMed ID: 8232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of liver dysfunction on the pharmacokinetics of carprofen.
    Holazo AA; Chen SS; McMahon FG; Ryan JR; Konikoff JJ; Brazzell RK
    J Clin Pharmacol; 1985 Mar; 25(2):109-14. PubMed ID: 3886707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, metabolism, and disposition of the antiinflammatory 3-[2-(4-methylphenyl)-thioethyl]-sydnone-5-14C in the rat.
    Pirl JN; Bell CL; Lu MC; Bauer L
    Arzneimittelforschung; 1985; 35(3):578-84. PubMed ID: 4039583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The disposition of 14C-indapamide in man.
    Klunk LJ; Ringel S; Neiss ES
    J Clin Pharmacol; 1983; 23(8-9):377-84. PubMed ID: 6630587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolism of the anti-inflammatory drug eterylate in rat, dog and man.
    Wood SG; John BA; Chasseaud LF; Johnstone I; Biggs SR; Hawkins DR; Priego JG; Darragh A; Lambe RF
    Xenobiotica; 1983 Dec; 13(12):731-42. PubMed ID: 6144210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dog.
    Wood SG; John BA; Chasseaud LF; Bonn R; Grote H; Sandrock K; Darragh A; Lambe RF
    Xenobiotica; 1987 Jul; 17(7):881-96. PubMed ID: 3660858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-performance liquid chromatographic determination of stereoselective disposition of carprofen in humans.
    Stoltenborg JK; Puglisi CV; Rubio F; Vane FM
    J Pharm Sci; 1981 Nov; 70(11):1207-12. PubMed ID: 6975367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of p-(cyclopropylcarbonyl)phenylacetic acid (SQ 20,650). Species Differences.
    Lan SJ; El-Hawey AM; Dean AV; Schreiber EC
    Drug Metab Dispos; 1975; 3(3):171-9. PubMed ID: 238816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic properties of carprofen in humans.
    Crevoisier C
    Eur J Rheumatol Inflamm; 1982; 5(4):492-502. PubMed ID: 7151844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolic disposition of 14C-ciramadol in humans.
    Sisenwine SF; Liu AL; Tio C; Kimmel H; Freeland G
    Xenobiotica; 1986 Apr; 16(4):335-40. PubMed ID: 3754997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mass balance study to evaluate the biotransformation and excretion of [14C]-triamcinolone acetonide following oral administration.
    Argenti D; Jensen BK; Hensel R; Bordeaux K; Schleimer R; Bickel C; Heald D
    J Clin Pharmacol; 2000 Jul; 40(7):770-80. PubMed ID: 10883419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and identification of carprofen and its in vivo metabolites in greyhound urine by capillary gas chromatography-mass spectrometry.
    Dumasia MC; Ginn A; Hyde W; Peterson J; Houghton E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 May; 788(2):297-307. PubMed ID: 12705970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
    Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
    Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and elimination of 14C-donepezil in healthy volunteers: a single-dose study.
    Tiseo PJ; Perdomo CA; Friedhoff LT
    Br J Clin Pharmacol; 1998 Nov; 46 Suppl 1(Suppl 1):19-24. PubMed ID: 9839761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and biotransformation of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S, 5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498) in rat, dog and man.
    Eckert HG; Badian MJ; Gantz D; Kellner HM; Volz M
    Arzneimittelforschung; 1984; 34(10B):1435-47. PubMed ID: 6097271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.